News summary

‘Light and sound’ therapy for Alzheimer’s flops in long-anticipated trial

Source: Nature - Main • Published: 17 Nov 2026, 00:00

Summarized by Masters of Longevity from Nature - Main.

A yearlong randomized trial found no cognitive benefit from the Spectris AD device.

‘Light and sound’ therapy for Alzheimer’s flops in long-anticipated trial
Key Takeaways
  • Trial was negative in 673 people with Alzheimer’s disease.
  • Active and sham groups declined by similar amounts.
  • Mild subgroup showed smaller effect but remains unproven.
Read the full article at Nature - Main ↗

Continue exploring

Recommended MoL Picks

MoL PickApple Brings Longevity to the Wrist. What Will It Change?Apple’s new Health Age, readiness and movement tools bring long-term health into everyday view. The opportunity is turning that information into useful action.MoL PickSeed Oils and Health: Inflammation, Processing and EvidenceHuman trials, processing risks and long-term health ask different questions. What can seed-oil research tell us—and what remains unresolved?MoL PickWhat Changes in the Human Hippocampus with Age?A study of 40 postmortem brains maps a midlife shift in immune cells and a wider loss of cellular and genome organisation—but it does not show how to prevent cognitive decline.